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ABSTRACT
The Immuno Polymorphism Database (IPD) (http://
www.ebi.ac.uk/ipd/) is a set of specialist databases
related to the study of polymorphic genes in the
immune system. IPD currently consists of four data-
bases: IPD-KIR, contains the allelic sequences of
Killer-cell Immunoglobulin-like Receptors; IPD-
MHC, a database of sequences of the Major
Histocompatibility Complex of different species;
IPD-HPA, alloantigens expressed only on platelets;
and IPD-ESTAB, which provides access to the
European Searchable Tumour Cell-Line Database, a
cell bank of immunologically characterized mela-
noma cell lines. The IPD project works with specialist
groupsornomenclaturecommitteeswhoprovideand
curate individual sections before they are submitted
toIPDforonlinepublication.TheIPDprojectstoresall
the data in a set of related databases. Those sections
withsimilardata,suchasIPD-KIRandIPD-MHCshare
the same database structure. The sharing of a com-
mon database structure makes it easier to implement
common tools for data submission and retrieval. The
data are currently available online from the website
and ftp directory; files will also be made available in
differentformatstodownloadfromthewebsiteandftp
server. The data will also be included in SRS, BLAST
and FASTA search engines at the European
Bioinformatics Institute.
INTRODUCTION
The Immuno Polymorphism Database (IPD) is a set of
specialist databases related to the study of polymorphic
genes in the immune system. The IPD project works with
specialist groups or nomenclature committees, which each
curate a different section of the project. IPD currently consists
of four databases: IPD-KIR, contains the allelic sequences
of Killer-cell Immunoglobulin-like Receptors (KIRs); IPD-
MHC, a database of sequences of the Major Histocompati-
bility Complex (MHC) of different species; IPD-HPA,
alloantigens expressed only on platelets; and IPD-ESTAB,
which provides access to the European Searchable Tumour
Cell-Line Database (ESTDAB), a cell bank of immunologi-
cally characterized melanoma cell lines.
The study of the immune system constitutes many different
complex areas ofresearch. Byproviding acentralized resource
for the work of different groups, it is hoped that we can bring
together similar data to aid in the study and analysis of this
area. This will be done by contacting various expert groups,
such as the nomenclature committees for certain genes, and
inviting them to contribute their data to a central resource. The
individual nomenclature committees are all established within
their own ﬁeld, their continuing role being the identiﬁcation
and naming of new alleles based on the submission of new
sequences to generalist databases like the European Molecular
Biology Laboratory’s nucleotide sequence database (EMBL),
the National Center for Biotechnology Information’s Gen-
Bank and the DNA DataBank of Japan (DDBJ). The main
difference between the data held within a specialist system
like IPD and the generalist databases is the further curation of
the ﬁles by experts in the relevant ﬁeld. This additional step
allows improvements in data quality and the addition of more
specialized information. This may result in there being differ-
ences in the entries kept in the different databases; in such
a case the entry in IPD should be considered as the most
accurate. The inclusion of some nomenclature committees
has meant the online publication of sequence alignments for
the ﬁrst time. This is particularly important when it comes to
the sequences of polymorphic genes. Also because the IPD
project is able to provide the work of different committees in
a common format, it is easier to compare the sequences of
different species.
The IPD project stores all the data in a set of related
databases. Those sections with similar data, IPD-KIR and
IPD-MHC share the same database structure. The sharing
of a common database structure makes it easier to implement
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unrelated sections like IPD-ESTDAB currently have their
own unique structure.
IPD-KIR
The KIRs are members of the immunoglobulin super family
(IgSF) formerly called Killer-cell Inhibitory Receptors. KIRs
have been shown to be highly polymorphic both at the allelic
and haplotypic levels (1). They are composed of two or three
Ig-domains, a transmembrane region and cytoplasmic tail,
which can in turn be short (activatory) or long (inhibitory).
The Leukocyte Receptor Complex (LRC), which encodes KIR
genes, has been shown to be polymorphic, polygenic and
complex in a manner similar to the MHC. This complexity
in sequences has led to the formation of the KIR nomenclature
committee. The nomenclature committee is responsible for the
naming ofnew allele sequences, and produced its ﬁrst report in
2002 (2); this was complemented by the inclusion of the KIR
data into IPD. The IPD-KIR Sequence Database contains the
most up-to-date nomenclature and sequence alignments. Also
available is an online submission tool that allows the sub-
mission of new and conﬁrmatory KIR sequences directly to
the KIR nomenclature committee.SequencessubmittedtoIPD
as part of the work of the individual nomenclature committees
are based on sequences currently found in the EMBL Nucleo-
tide Sequence Database (EMBL) (3), GenBank (4) and the
DDBJ (5). Indeed a requirement of all submissions to IPD is
that they have been submitted to these more general databases.
Future developments of the IPD-KIR section will involve
working with the KIR nomenclature committee to provide
nomenclature and tools for study of the complex haplotypes
and genotypes currently seen in KIR research.
IPD-MHC
The MHC sequences of many different species have been
reported previously (6–9), along with different nomenclature
systems used in the naming and identiﬁcation of new genes
and alleles in each species. The sequences of the MHC from a
number of different species are highly conserved between
species (10). By bringing the work of different nomenclature
committeesand the sequences ofdifferent species togetherit is
hoped to provide a central resource that will facilitate further
research on the MHC of each species and on their comparison.
The ﬁrst release of the IPD-MHC database involved the
work of groups specializing in non-human primates, canines
(DLA) and felines (FLA) and incorporated all data previously
available in the IMGT/MHC database (11). This release
included data from 5 species of ape, 16 species of new world
monkey, 17 species of old world monkey, as well as data on
different canines and felines. Since the ﬁrst release, we have
been able to add sequences from cattle (BoLA), and are now
working to include the MHC sequences from swine (SLA),
chickens, horses (ELA) and rats (RT1).
For each species, there are some differences in the spectrum
of data covered but all sections provide the core nomenclature
pages and sequence alignments. The nomenclature and align-
mentsfollow a similar structureto that ofthe IPD-KIR section,
and the same basic tools are used in both sections. Currently,
the IPD-MHC sequence alignments are limited to species-
speciﬁc alignments; however, we are working to allow cross-
species alignments and the inclusion of human sequences from
the IMGT/HLA database (12) for comparative purposes. The
IPD-MHC Sequence Databases will also contain a submission
tool for online submission of new and conﬁrmatory sequences
to the appropriate nomenclature committee.
COMMON TOOLS FOR IPD-KIR AND IPD-MHC
Some sections of the project are clearly more closely related,
namely the IPD-KIR and IPD-MHC sections, both deal with
sequences from polymorphic genes and as such they share
a number of features. As each section is based on the work
ofanomenclaturecommittee,the website includes orlinkstoa
portable document format (PDF) ﬁle of recent nomenclature
reports. The website also provides a recognized location for
updates to the nomenclature between published reports. These
pages contain the ofﬁcial allele name, any previous designa-
tions, the EMBL, GenBank or DDBJ accession number(s) and
a reference linked wherever possible to the PubMed abstract.
If possible additional details on the source of sequence are
also provided. Some nomenclature committees may provide
additional information but the core components of any nomen-
clature reported are the allele names, accession numbers and
publications.
The second common feature is the sequence alignment tool,
which is provided using a common interface for both sections.
Figure 1 shows the alignment tool used for the IPD-KIR sec-
tion.Themain difference seen in the IPD-MHC interface isthe
locus listing, which is also preceded by a species listing. The
selection of a locus, automatically updates the list of features,
which can be aligned,as well as the default reference sequence
used for the alignment. The remaining options cover display
and formatting options. The alignment tool uses standard for-
matting conventions for the display of sequence alignments;
these are based on those currently used by the IMGT/HLA
Sequence Database (11–14) and published recommendations
for Human Gene Mutations (15,16). The alignment tool
options allow the user to display a subset of alleles of a parti-
cular locus, omit alleles unsequenced for a particular region
and align against a particular reference or consensus sequence.
In addition, the sequences can be displayed as complete
nucleotide sequence, partial sequences of single exons or
the amino acid sequence of the encoded protein (Figure 2).
The alignment tool does not perform a sequence alignment
each time it is used, but it extracts pre-aligned sequences,
allowing for faster access. For some of the sections included,
this is the ﬁrst time users have been able to view sequence
alignments online.
IPD-HPA
Human platelet antigens (HPAs) are alloantigens expressed
only on platelets, speciﬁcally on platelet membrane glycopro-
teins. These platelet-speciﬁc antigens are immunogenic and
can result in pathological reactions to transfusion therapy. The
HPA nomenclature system was adopted in 1990 (17,18) to
overcome problems with the previous nomenclature. Since
then more antigens have been described and the molecular
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was revised in 2003 (19) and included in the IPD project. The
IPD-HPA section contains nomenclature information and
additional background material. The different genes in the
HPA system have not been sequenced to the same level as
some of the other projects and so currently only single
nucleotide polymorphisms (SNPs) are used to determine
alleles. This information is presented in a grid of SNP for
each gene. The IPD and HPA nomenclature committee
hope to expand this to provide full sequence alignments
when possible.
IPD-ESTDAB
IPD-ESTDAB is a database of immunologically characterized
melanoma cell lines. The database works in conjunction
with the European Searchable Tumour Cell Line Database
(ESTDAB) cell bank, which is housed in T€ u ubingen, Germany
and provides immunologically characterized tumour cells.
The IPD-ESTDAB section of the website provides an online
search facility for cells stored in this cell bank. This enables
investigators to identify cells possessing speciﬁc parameters
important for studies of immunity, immunogenetics, gene
expression, metastasis, response to chemotherapy and other
tumour biological experimentation. The search tool allows for
searches based on a single parameter, or clusters of parameters
on over 250 different markers for each cell. The detailed
reports produced can then be used to identify cells of interest,
which in turn can then be obtained from the cell bank.
DISCUSSION
The IPD project provides a new resource for those interested
in the study of polymorphic sequences in the immune system.
Figure 2. Alignment formats available from IPD. The examples shown are all alignments of DRB alleles from different species. In these alignments a dash (-)
indicates identity to the reference sequence and an asterisk (*) denotes an unsequenced base. The first alignment shows the nucleotide sequence of Chimpanzee
(Pan troglodytes) DRB1 alleles with the human HLA-DRB1*010101 allele. The nucleotide sequence is also displayed in amino acid codons; the first base of the
initialcodonisencodedinexon1andsonotdisplayedinthisalignment.ThesecondsetofsequencesshowsDRBallelesfromcattle.Thefinalalignmentusescanine
DRB alleles, and demonstrates how the full sequence can be displayed.
Figure 1. The alignment interface provides a user-friendly method of viewing sequence alignments with output options easily selected.
Nucleic Acids Research, 2005, Vol. 33, Database issue D525By accommodating related systems in a single database, data
can be made available in common formats aiding use and
interpretation. As the projects grow and more sections are
added, the beneﬁt of having expertly curated sequences
from related areas stored in a single location will become
more apparent. This is particularly true of the IPD-MHC
project, where cross-species studies will be able to utilize
the high-quality sequences provided by the different nomen-
clature committees in a common format, ready for use. The
initial release of the IPD Databasecontained onlyfour sections
and a small number of tools; however, as the database grows
and more sections and species are added, more tools will be
added to the website. We plan to use the existing database
structures to house data for new sections of the IPD project as
they become available. The ﬁles will also be made available
in different formats for downloading from the website, and ftp
server, and the data will be included in SRS, BLAST
and FASTA search engines at the European Bioinformatics
Institute (20).
ACCESS AND CONTACT
IPD Homepage: http://www.ebi.ac.uk/ipd/
IPD-KIR Homepage: http://www.ebi.ac.uk/ipd/kir/
IPD-MHC Homepage: http://www.ebi.ac.uk/ipd/mhc/
IPD-HPA Homepage: http://www.ebi.ac.uk/ipd/hpa/
IPD-ESTDAB Homepage: http://www.ebi.ac.uk/ipd/estdab/
Contact: ipd@ebi.ac.uk
If you are interested in contributing to the project, there are
speciﬁc guidelines for the inclusion of new sections, and inter-
ested parties should contact Dr S. G. E. Marsh,marsh@ebi.ac.uk
for further information.
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